Clinical trial Recruiting at 1 site Interventional Ages 8 to 10

Teaching inner speech to help children with developmental language disorder

Official title: Training Verbal Mediation to Support Executive Function in Children With Developmental Language Disorder

Run by MGH Institute of Health Professions · NCT06880731 · Data updated 2026-11-12

This project tests whether modeling self-directed 'inner speech' helps children with developmental language disorder improve their ability to switch between tasks and control behavior.

Quick facts

Study typeInterventional
Ages8 Years to 10 Years
SexAll
Enrollment75 (estimated)
SponsorMGH Institute of Health Professions
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedNovember 21, 2025
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedDecember 15, 2025
Trial IDNCT06880731 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 8;0–9;11 years with primary English, normal hearing on screening, TILLS Identification Core Score <34, KBIT-2 Fluid Subtest standard score ≥70, and no ADHD, autism, TBI, or other neurological disorders are the intended participants.

Probably not a fit

Children with co-occurring ADHD, autism, traumatic brain injury, significant hearing loss, non-English primary language, or KBIT-2 Fluid Subtest <70 are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project enrolls 75 children aged 8 to 10 years divided into three matched groups: DLD-training (modeling verbal mediation), DLD-control (modeling only), and a typically developing control. The DLD-training group receives modeled verbal mediation intended to shape use of self-directed language, while controls receive modeling without the verbal mediation component. Outcome measures include behavioral metrics (accuracy and reaction time) and an electrophysiological EEG marker of cognitive shifting to capture real-time cue processing. Investigators will compare changes in use of verbal mediation and both behavioral and EEG measures of shifting to determine whether the training improves executive function in children with DLD.

Why it matters

Potential benefit: If successful, the approach could give children with DLD better self-guided language strategies and improved cognitive flexibility that may help academic and everyday functioning.

How similar studies have gone: Language-based modeled interventions have shown promise in improving verbal mediation and executive function in typically developing children, but applying this approach to children with DLD is relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria (children with developmental language disorder; DLD):

* Age 8;0-9;11 years English as the primary language
* Pass hearing screen bilaterally (20 dB HL, at 1K, 2K, \& 4K)
* TILLS Identification Core Score \< 34

Inclusion criteria (children with typical development; TD):

* Age 8;0-9;11 years English as the primary language
* Pass hearing screen bilaterally (20 dB HL, at 1K, 2K, \& 4K)
* TILLS Identification Core Score \> or = 34

Exclusion criteria (DLD \& TD groups):

* KBIT-2 Fluid Subtest Standard Score \< 70
* ADHD, Autism, TBI, or other neurological deficits or disorders

Where it's running

  • MGH Institute of Health Professions
    Boston, Massachusetts, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.